Thyme Care — Valuation, Funding & Investors

Recent changes

Sep 4, 2026Sep 4, 2026Raised $125M Series E at a $2 billion valuation CNBC
Sep 4, 2026Sep 4, 2026Thyme Care Doubles to $2B on Cancer Navigation Pulse story

Funding History

1 event · sources dated per row

Date	Event	Amount	Valuation	Investors	Source
Sep 4, 2026	Series E	$125M	$2 billion	Morgan HealthJPMorgan's health investment arm	Pulse story

Latest Pulse

Sep 4, 2026Thyme Care Doubles to $2B on Cancer NavigationMorgan Health led a $125 million Series E with Humana and CVS Health Ventures joining, as the Nashville company's oncology navigation service reached 135,000 actively treated patients.→

Coverage Timeline

newest first

Sep 4, 2026FUNDINGThyme Care Doubles to $2B on Cancer Navigation$125M Series E→

All Coverage

FUNDING· Sep 4, 2026

Thyme Care Doubles to $2B on Cancer Navigation

FUNDING$125M Series E

Thyme Care Doubles to $2B on Cancer Navigation

Morgan Health led a $125 million Series E with Humana and CVS Health Ventures joining, as the Nashville company's oncology navigation service reached 135,000 actively treated patients.

Sep 4, 2026DEEP DIVE

Sources & methodologyshow

Where these figures come from

CNBCmajor outlet1 fact

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction